Cancer care is becoming a data problem. FDA cleared a pan-cancer genomic profiling kit in 2024: 500 genes from one biopsy to match patients to targeted therapies [1]. Genomics England linked whole-genome data from 13,880 tumors to real-world outcomes [2]. 🧬 That shifts power to labs, AI teams, tumor boards and payers. Fast matching is becoming a competitive advantage and an equity risk [3]. The bottleneck is not sequencing. It is reimbursement, data sharing and access beyond elite centers. ⚕️ 🤔 Where will precision oncology break first: evidence, equity, economics, or execution? [1] [ascopost.com/news/august-202…](ascopost.com/news/august-202…) [2] [nature.com/articles/s41591-0…](nature.com/articles/s41591-0…) [3] [oncokb.org/companion-diagnos…](oncokb.org/companion-diagnos…) #PrecisionOncology #GenomicProfiling #CancerCare

📜#mdpidermatopathology New Publication: Comprehensive Genomic Profiling of Cutaneous Adnexal Carcinomas: A Genomic Landscape Study by Jeffrey Ross et al. 🔗Access for free: mdpi.com/3818470 #CutaneousAdnexalCarcinomas #genomicprofiling #rareskincancers

🧬 Precision Insight for Prostate Cancer Care Serial liquid biopsies are changing how clinicians monitor metastatic castration-resistant prostate cancer. A large real-world study shows that androgen receptor (AR) alterations repeatedly appear across ARPIs, PARP inhibitors, and chemotherapy, and are linked to shorter survival and faster treatment failure. 🔗 Read full article at: ow.ly/kUvH50YmOEg By tracking circulating tumor DNA over time, researchers demonstrated that one-time genomic testing may miss critical, treatment-related molecular shifts. Real-time ctDNA monitoring offers a clearer picture of resistance biology and may support more timely, personalized treatment decisions for men with advanced disease. 👩‍⚕️👨‍⚕️ Relevant for oncologists, urologists, oncology nurses, and precision medicine teams. Credit: @umiamimedicine #AdvancedProstateCancer #Liquidbiopsy #ctDNAtesting #Androgenreceptor #Precisiononcology #ARpathwayinhibitors #Genomicprofiling #castration #prostatecancer #chemotherapy #cancercare #Tumor #CancerResearch #eMedEvents

Missed our latest webinar? It’s now on YouTube! Dr. James Chen, medical oncologist specializing in sarcomas at @OSUCCC_James & Senior VP of Medical Informatics at @TempusAI, explains why #genomicprofiling matters for #EHE and its impact on care. youtu.be/DEhVAiM_Zws?si=Z41l…

#ESMOAsia25: Studies in cancer of unknown primary (#CUP) highlight the need to perform routine comprehensive #GenomicProfiling and then provide access to the appropriate #TargetedTherapy. Find out more in the #ESMODailyReporter ➡️ow.ly/FSyu50XF5t1

Happening in 2 weeks! Join us for a conversation on #genomicprofiling — a key tool driving treatment decisions, clinical trials, & future progress in #EHEresearch. Dr. Chen will break down what next-generation sequencing is and why it matters. @TempusAI fightehe.org/ehe-360-connect…

New analysis: CGP for metastatic cancer patients can extend lives & reduce costs: ❤️ Add 3,440 life-years 💰 Potential healthcare system savings of $87M - $134M 🔗conferenceboard.ca/product/g… @ConfBoardofCda #PrecisionInPractice #GenomicProfiling #CancerInnovation

❓Do you know your EHE subtype? TAZ-CAMTA1, YAP1-TFE3, or a wild type! 👉 Learn more at the next EHE 360 Connect 🗓️ Thursday, 12/4 ⏰ 12-1 pm ET 📣 Dr. James Chen, @OSUCCC_James @TempusAI fightehe.org/ehe-360-connect… #EHE #epithelioidhemangioendothelioma #genomicprofiling

Join our FREE roundtable on bridging testing gaps and expanding patient access to comprehensive genomic profiling. Learn strategies to improve CGP outcomes. Register now: hubs.li/Q03K-Scp0 @Labcorp #CGP #GenomicProfiling #HealthcareInnovation

Day 2 | #ESMO25 Mini Oral 🧬 Can genomic profiling truly change outcomes in rare cancers? 🔹 IMPRESS-Norway: 16-wk DCR 46% (1% CR, 19% PR, 25% SD) 🔹 MD Anderson Rare Tumor Initiative (113MO): 1,100 pts, 106 rare cancer types profiled via WES/WGS, WTS, mIF → Uncovered key tumor-intrinsic & microenvironmental states, → Revealed therapeutic target pathways for future strategies. Promise is real — but access, prospective data & equitable therapy availability remain major challenges. #ESMO25 #OncoDaily #OncoAlert #OncoLive #ClinicalResearch #ClinicalTrials #PrecisionOncology #RareCancers #GenomicProfiling

#ESMO25: What is the clinical value of #GenomicProfiling in #RareCancers? @Timothee_MD discusses how comprehensive and prospective data are required to support wider implementation. #ESMODailyReporter 👉 ow.ly/eswu50Xesub #PrecisionOncology

#PathologyHorizons2025 is off to a fantastic start! Our first speaker, Catherine Mitchell, has delivered a fascinating session on the evolving role of comprehensive #GenomicProfiling in #TumourDiagnosis & #Classification. Thank you Catherine for kicking off #PathologyHorizons!

Lung cancer demands precision. Comprehensive #GenomicProfiling can reveal actionable insights and targeted therapy options. Explore our comprehensive tissue and #LiquidBiopsy solutions: neogenomics.com/providers/on…

At @KDAHMumbai, we’re proud to launch OncoKH 500 PLUS, our advanced in-house genomic profiling test that screens 500 cancer-related genes in a single run. This powerful tool helps our oncologists make more accurate, faster, and tailored treatments to each patient’s unique cancer profile, bringing world-class, personalised care right here in India. expresshealthcare.in/news/ko… #OncoKH500PLUS #GenomicProfiling #GenomicTesting #CancerCare #KDAHMumbai

The August issue of @JMDiagn is now live online! Full issue: jmdjournal.org/issue/S1525-1… #germline #genomicprofiling #mutation #

Comprehensive Genomic Profiling as a Critical tool for detecting Important Biomarker - Michelle Green oncodaily.com/url/310400 #Cancer #OncoDaily #Oncology #GlobalAwareness #FightAgainstCancer #CancerWorld #GenomicProfiling

🧬🔍 New insights into #uterine #leiomyosarcoma! A study presented at #ASCO25 analyzes the genetic profile of LMS using a national database. 📄 Read more: buff.ly/c5D5GES #UterineCancer #GenomicProfiling #CancerResearch #ASCO25

Somatic or Germline? Enhancing Tumor Profiling Accuracy Accurate genomic profiling is essential for clinical decision-making and optimizing treatment recommendations. Sponsored by @SOPHiAGENETICS #LiquidBiopsy #NGS #GenomicProfiling #cancer #tumor hubs.li/Q03p-pBC0

Enjoyed presenting our work on #GenomicProfiling of #BiliaryTractCancers at the 30th Annual @OhioStateSurg Research conference. Terrific science and presentations by all participants today.

🚨 The right #lungcancer treatment starts with the right test. But not everyone in Europe is getting it. Comprehensive Genomic Profiling (CGP) can match people to targeted treatments—yet access remains limited & unequal. This needs to change. The new ECGP recommendations outline how. 🔗 Read more: lungcancereurope.eu/wp-conte… #LCSM #GenomicProfiling #TargetedTherapy